| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2008) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| ATC: | L04AC04 |
| UNII: | 8K80YB5GMG |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Pericarditis | 4 | D010493 | ClinicalTrials |
| Gout | 3 | D006073 | ClinicalTrials |
| Familial Mediterranean Fever | 2 | D010505 | ClinicalTrials |
| Hepatitis, Alcoholic | 2 | D006519 | ClinicalTrials |
| Arthritis, Juvenile | 2 | D001171 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 1 | D003922 | ClinicalTrials |
| Scleroderma, Diffuse | 1 | D045743 | ClinicalTrials |
| Hearing Loss | 0 | D034381 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 501081-76-1 |
| ChEMBL | CHEMBL1201830 |
| FDA SRS | 8K80YB5GMG |
| Guide to Pharmacology | 6790 |
CONTENTS